Yabao Pharmaceutical Group Co., Ltd.

Inspur Suzhou Intelligent Technology Co., Ltd

Jiangsu Contemporary Amperex Technology Limited

Suzhou Pengxu Pharmatech Co., Ltd.

Suzhou Yabao Pharmaceutical R&d Co., Ltd.

Wuhan University

State Grid Jiangsu Electric Power Company

Lansion Biotechnology Co., Ltd.

Shanxi Yabao Health Products Co., Ltd.

Jiangsu Simovay Pharmaceutical Co., Ltd.

Shanxi Yabao Investment Group Co., Ltd.

Peng Wang

Lin Zhu

Pixu Li

Qiang Wei

Fei Zhang

Wen Cheng

Lili Sun

Jian Xu

Lei Wang

Tao Wang

Xingshang Xu

Jeffery Chen

Yang Xu

Fang Fang

Chong Tong

Hao Wu

Xinxiang Chen

Yulian Zheng

Yongling Lu

Wenyu Liu

Mingyang Ye

Wuxian Ren

Siyang Liao

Huasheng Su

Shoujun Huang

Chengyou Xing

Longling Sun

Shichao Cheng

Junlin Su

Dan Wang

Yuyong Lei

Zhijian Wu

Jianguo Zhang

Bangqin Ya

Rong Chen

Lin Feng

Zhengping Zhang

Qingli Dong

Fulong Li

Yao Hua

Weiliang Wang

Zhihao Fang

Yi Hong

Jinwen Mai

Min Xiang

Jiahuan Feng

Qi Pan

Dongsheng Jing

The present disclosure provides a top cover assembly for a battery, a battery and a device using a battery as a power source. The top cover assembly includes: a cover plate body having a liquid injection hole; a mounting part configured to be connected with the cover plate body and arranged around the liquid injection hole; a sealing element configured to be connected with the mounting part, wherein the sealing element includes a first top wall and a first side wall connected to the periphery of the first top wall, the first top wall is configured to cover the liquid injection hole, and the first side wall is configured to be in press fit with the mounting part to achieve sealing of the liquid injection hole; and a fixing element configured to be connected with the cover plate body and to fix the sealing element to the mounting part.

Top cover assembly including fixing element for fixing sealing element to mounting part and battery including the same

The present application provides a upadacitinib salt compound and a preparation method therefor. The salt involved in the method in the present application has an easy preparation operation, a cheap raw material easy to get, and a good purification effect on upadacitinib, and is beneficial to industrial production.

Crystalline form of Di-p-toluoyl-L-tartrate of upadacitinib

A top cover assembly of a battery cell, a battery cell, and a battery module. The top cover assembly of the battery cell includes: a separator plate and a top cover assembly. The separator plate is provided with sampling channel(s) for accommodating a sampling member. The top cover plate is configured for sealing an electrode assembly of the battery cell into the battery housing, where the top cover plate is provided below the separator plate, and the separator plate is fixed to the top cover plate.

Top cover assembly, battery cell, battery module and manufacturing methods therefor

The present disclosure relates to a JAK inhibitor upadacitinib intermediate and a preparation method therefor, and to a preparation method for a JAK inhibitor upadacitinib. The upadacitinib intermediate of the present application is as shown in Formula (II) or Formula (III),

Synthesis methods for upadacitinib and intermediate thereof

Disclosed is a JTAG-based burning device, including controllable switches arranged between a TDI terminal of a JTAG host and a first chip, and between two adjacent chips, and further including a master controllable switch module arranged between each chip and a TDO terminal of the JTAG host, wherein the JTAG host may, according to a received burning instruction, control corresponding input terminals of the controllable switches to be connected to corresponding output terminals and also control an output terminal of the master controllable switch module to be connected to the corresponding input terminal. Obviously, a JTAG chain can be automatically adjusted by controlling the connection relationship between input and output terminals of the corresponding switches by only building a circuit, so that firmware burning on different chips or chip combinations is realized without manual adjustment, thereby improving the test efficiency, and simplifying the circuit structure.

JTAG-based burning device

Disclosed are a power consumption reduction circuit for Graphics Processing Units (GPUs) in a server and a server. The power consumption reduction circuit includes a frequency reduction control chip. The frequency reduction control chip, after receiving an overpower alarm signal generated by a Power Supply Unit (PSU), generates a frequency reduction control signal to a Power Break (PWRBRK) pin of each GPU so as to start a frequency reduction operation of each GPU. It can be seen that, in the present application, an underlying hardware circuit is directly used for implementation with relatively quick responses and without intervention of an operating system, whereby the whole frequency reduction operation of the GPU may be completed within 5 ms, and the PSU is prevented from triggering overpower protection within relatively short time. Therefore, loss of service data of a user caused by an exceptional power failure of the server is avoided.

Power consumption reduction circuit for GPUs in server, and server

A method for assigning an antibody standard and determining a minimum detection limit of an antibody detection reagent specifically includes the following steps: S1, determination of a neutralized antigen equivalent of an antibody standard or a sample: an antigen with a known purity and concentration is subjected to a gradient dilution using a matrix, an equal amount of an antibody standard or antibody-containing sample is added to each of the gradient diluents with different concentrations respectively, and after a reaction, each mixture is subjected to an antibody detection using a first antibody detection reagent, to determine the neutralized antigen equivalent of the antibody standard or sample; S2, determination of an antibody titer of the sample; and S3, acquisition of the minimum detection limit of an antibody detection reagent.

Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent

A lightning strike probability-based coordinated power control method for an energy storage system and a load adjusts output power of an energy storage system and a regulatable load based on a real-time predicted lightning strike probability. This reduces a correlation between a power grid in a lightning region and an external power grid, minimizes impact of a lightning strike if any on the external power grid, and decreases an economic loss due to the lightning strike in the lightning region. The present disclosure establishes a relationship between the output power of the energy storage system, the regulated power of the regulatable load, and a lightning strike probability in a same region, and then regulates the power of the energy storage system and the regulatable load in real time based on the lightning strike probability.

Lightning strike probability-based coordinated power control method for energy storage system and load

A pyranoglucose-substituted pyrazole compound, used as a pharmaceutical intermediate, having the structural formula represented by formula (9c). The present invention further relates to an intermediate compound represented by formula (10c) or a salt thereof. The present invention further relates to a preparation method of the aforementioned intermediate compound and a method of using the same to prepare an SGLT inhibitor. By means of the novel key intermediate, the preparation technique of an SGLT inhibitor is greatly simplified. In addition, because the intermediate can be precipitated in the form of a salt and is easy to purify, the purity of the SGLT inhibitor is significantly increased, compared with the original preparation pathway (crude product purity can reach 99% or more). (I) 

Pyranoglucose-substituted pyrazole compound, preparation method thereof and application thereof

The present application relates to a salt of a pyranose-substituted heterocyclic compound, a preparation method therefor, and use thereof, and in particular, to an acid addition salt of a compound of formula (I) or a prodrug thereof, and further relates to D-glucuronate of a crystalline compound of formula (I) or a prodrug thereof. D-glucuronate of a crystalline compound of formula (II) has particular advantages in terms of crystallizability, subsequent purification, stability, formulation medicinal properties or quality control, and is most applicable for improving the formulation pharmaceutical properties, purity and quality control, as well as large-scale process development of such drugs.

Salt of pyranose-substituted heterocyclic compound, preparation method therefor and use thereof

Provided is a use of dihydroxyacetone in the preparation of a medicament, the medicament being used for treating a cancer.

Use of dihydroxyacetone in preparation of anti-cancer medicaments

Disclosed are 1,4-dihydro-naphthyridine derivatives and pharmaceutical composition and uses thereof. The 1,4-dihydro-naphthyridine derivatives are a compound capable of inhibiting acetylcholinesterase activity and preventing extracellular calcium from flowing into a cell via a calcium channel, i.e., having a dual-activity, which are of potential importance as a pharmaceutical and can be used to prepare the drugs for treating cardiovascular diseases, cerebrovascular diseases and dementia.

1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof

Growing community of inventors

Jiangsu, China

Peng Wang